Table of Contents
A new study suggests that a non-invasive brain scan can detect preserved cognitive function in individuals with Alzheimer’s disease (AD), even as conscious awareness declines. The findings offer hope for refining treatment strategies and improving the quality of life for those living with this devastating condition.
As Alzheimer’s progresses from mild cognitive impairment to severe dementia, the brain’s ability to process complex thoughts diminishes, though basic sensory awareness often remains. Researchers have long understood that certain unconscious cognitive processes – like procedural memory (often called “muscle memory”) – are more resilient to the disease. This new research delves deeper into quantifying the extent of these preserved abilities.
Measuring Brain Complexity with PCI-ST
The study, conducted by researchers at Boston University Chobanian & Avedisian School of Medicine, utilized a measure called the perturbation complexity index-state transitions (PCI-ST). This index is calculated by recording electroencephalogram (EEG) signals after delivering a pulse of transcranial magnetic stimulation. Previously used to differentiate between coma and minimally conscious states, the researchers explored whether PCI-ST could reveal the integrity of conscious processing in AD patients.
The results were compelling. Researchers found that brain complexity, as measured by PCI-ST, was significantly reduced in individuals with AD compared to a control group of healthy aging adults. This suggests PCI-ST can effectively reflect the impaired cognitive processes and functional capacity characteristic of the disease.
The Power of “Muscle Memory”
“Despite their impaired conscious memory, individuals with Alzheimer’s disease may be able to use intact implicit, unconscious forms of memory, such as procedural memory to continue their daily routines at home,” explained a senior author of the study. “When they travel, however, their home routines are not helpful and their dysfunctional conscious memory can lead to disorientation and distress.”
The research team assessed 28 participants with AD and 27 healthy controls, carefully measuring their cognitive abilities and the severity of their condition. Lower PCI-ST scores were observed in the AD group across both the motor cortex and parietal stimulation sites, further supporting the link between PCI-ST and cognitive impairment.
Implications for Future Research and Treatment
This research opens exciting new avenues for understanding the complexities of dementia. “This research opens the avenue for future studies in individuals with cortical dementia to examine the relationship between conscious processes, global measures of consciousness, and their underlying neuroanatomical correlates, in addition to enhancing our understanding of dementia and suggesting possible therapeutic strategies,” stated a lead researcher.
Furthermore, the findings highlight the potential of leveraging preserved unconscious memory functions in treatment. Existing pharmacologic therapies, such as donepezil (Aricept) and memantine (Namenda), aim to improve conscious abilities by altering neurotransmitter levels. However, non-pharmacological interventions can also be designed to capitalize on intact procedural memory and other unconscious processes, potentially strengthening habits and improving quality of life for those with AD.
